Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Propensity Score Matched Analysis of Statin Effects on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients Over 75 Years Old.
Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Watanabe Y, Uematsu M, Makino A, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Watanabe A, Asakawa T, Sato A, Kugiyama K. Horikoshi T, et al. Among authors: kugiyama k. Intern Med. 2022 Sep 15;61(18):2711-2719. doi: 10.2169/internalmedicine.8932-21. Epub 2022 Feb 26. Intern Med. 2022. PMID: 35228422 Free PMC article.
Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy.
Uematsu M, Nakamura T, Sugamata W, Kitta Y, Fujioka D, Saito Y, Kawabata K, Obata JE, Watanabe Y, Watanabe K, Kugiyama K. Uematsu M, et al. Among authors: kugiyama k. Circ J. 2014;78(1):151-8. doi: 10.1253/circj.cj-13-0783. Epub 2013 Nov 12. Circ J. 2014. PMID: 24225306 Free article. Clinical Trial.
Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.
Fujihara Y, Nakamura T, Horikoshi T, Obata JE, Fujioka D, Watanabe Y, Watanabe K, Kugiyama K. Fujihara Y, et al. Among authors: kugiyama k. Circ J. 2019 May 24;83(6):1302-1308. doi: 10.1253/circj.CJ-19-0047. Epub 2019 Apr 18. Circ J. 2019. PMID: 30996151 Free article. Clinical Trial.
Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.
Horikoshi T, Obata JE, Nakamura T, Fujioka D, Watanabe Y, Nakamura K, Watanabe K, Saito Y, Kugiyama K. Horikoshi T, et al. Among authors: kugiyama k. J Atheroscler Thromb. 2019 Dec 1;26(12):1062-1074. doi: 10.5551/jat.48249. Epub 2019 Apr 16. J Atheroscler Thromb. 2019. PMID: 30996201 Free PMC article.
Improvement in Brachial Endothelial Vasomotor Function and Brachial-Ankle Pulse Wave Velocity Reduces the Residual Risk for Cardiovascular Events after Optimal Medical Treatment in Patients with Coronary Artery Disease.
Nakamura T, Uematsu M, Horikoshi T, Yoshizaki T, Kobayashi T, Saito Y, Watanabe Y, Nakamura K, Obata JE, Kugiyama K. Nakamura T, et al. Among authors: kugiyama k. J Atheroscler Thromb. 2021 Nov 1;28(11):1133-1144. doi: 10.5551/jat.57562. Epub 2020 Nov 20. J Atheroscler Thromb. 2021. PMID: 33229855 Free PMC article.
260 results